KRAS and pancreatic neoplasm: To further reinforce the notion that ERA and FR054 treatment could cooperate in inducing ferroptosis in PDAC cell models, we treated human pancreatic cancer PANC1 cells, characterized by K-Ras mutation and a great sensitivity to cysteine depletion, with ERA and FR054 alone or in combination along a time course of 72 h.